Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.
about
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.Metastasis of Pregnancy-Associated Breast Cancer (Suspected to Be Hereditary Breast and Ovarian Cancer) to the Brain, Diagnosed at 18 Weeks' Gestation: A Case Report and Review of the Literature.Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.
P2860
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk factors for endometrial c ...... utation: a case control study.
@en
Risk factors for endometrial c ...... utation: a case control study.
@nl
type
label
Risk factors for endometrial c ...... utation: a case control study.
@en
Risk factors for endometrial c ...... utation: a case control study.
@nl
prefLabel
Risk factors for endometrial c ...... utation: a case control study.
@en
Risk factors for endometrial c ...... utation: a case control study.
@nl
P2093
P2860
P50
P1433
P1476
Risk factors for endometrial c ...... utation: a case control study.
@en
P2093
Andrea Eisen
Barry Rosen
Beth Karlan
Charis Eng
Charmaine Kim-Sing
David Euhus
Dawna Gilchrist
Eitan Friedman
Henry T Lynch
Hereditary Breast Cancer Study Group
P2860
P2888
P304
P356
10.1007/S10689-015-9798-8
P577
2015-04-03T00:00:00Z